Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12916058rdf:typepubmed:Citationlld:pubmed
pubmed-article:12916058lifeskim:mentionsumls-concept:C0019704lld:lifeskim
pubmed-article:12916058lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:12916058lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:12916058lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:12916058lifeskim:mentionsumls-concept:C0243071lld:lifeskim
pubmed-article:12916058lifeskim:mentionsumls-concept:C0679622lld:lifeskim
pubmed-article:12916058lifeskim:mentionsumls-concept:C0205314lld:lifeskim
pubmed-article:12916058lifeskim:mentionsumls-concept:C0248122lld:lifeskim
pubmed-article:12916058pubmed:issue4-5lld:pubmed
pubmed-article:12916058pubmed:dateCreated2003-8-13lld:pubmed
pubmed-article:12916058pubmed:abstractTextBis(alken-1-yloxy)methanes 2 were synthesized by reacting 2-cyclohexenol, 3-cyclohexenylmethanol, cinnamyl alcohol and its alpha-methyl analogue with dibromomethane. Condensation of 2 with 5, 6-disubstituted uracil derivatives 1 resulted in the desired MKC-442 analogues 3-6. The most active compounds, N-1 cinnamyloxymethyl- and N-1 2-methyl-3-phenylallyloxymethyl substituted 5-ethyl-6-(3, 5-dimethylbenzyl)uracils (5b and 6b), showed activity against wild-type HIV-1 in the nanomolar range, and against Y181C andY181C+K103N, mutant strains known to be resistant to MKC-442, in the micromolar range.lld:pubmed
pubmed-article:12916058pubmed:languageenglld:pubmed
pubmed-article:12916058pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12916058pubmed:citationSubsetIMlld:pubmed
pubmed-article:12916058pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12916058pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12916058pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12916058pubmed:statusMEDLINElld:pubmed
pubmed-article:12916058pubmed:monthJullld:pubmed
pubmed-article:12916058pubmed:issn0365-6233lld:pubmed
pubmed-article:12916058pubmed:authorpubmed-author:NielsenClausClld:pubmed
pubmed-article:12916058pubmed:authorpubmed-author:PedersenErik...lld:pubmed
pubmed-article:12916058pubmed:authorpubmed-author:El-BrollosyNa...lld:pubmed
pubmed-article:12916058pubmed:issnTypePrintlld:pubmed
pubmed-article:12916058pubmed:volume336lld:pubmed
pubmed-article:12916058pubmed:ownerNLMlld:pubmed
pubmed-article:12916058pubmed:authorsCompleteYlld:pubmed
pubmed-article:12916058pubmed:pagination236-41lld:pubmed
pubmed-article:12916058pubmed:dateRevised2009-8-19lld:pubmed
pubmed-article:12916058pubmed:meshHeadingpubmed-meshheading:12916058...lld:pubmed
pubmed-article:12916058pubmed:meshHeadingpubmed-meshheading:12916058...lld:pubmed
pubmed-article:12916058pubmed:meshHeadingpubmed-meshheading:12916058...lld:pubmed
pubmed-article:12916058pubmed:meshHeadingpubmed-meshheading:12916058...lld:pubmed
pubmed-article:12916058pubmed:meshHeadingpubmed-meshheading:12916058...lld:pubmed
pubmed-article:12916058pubmed:meshHeadingpubmed-meshheading:12916058...lld:pubmed
pubmed-article:12916058pubmed:meshHeadingpubmed-meshheading:12916058...lld:pubmed
pubmed-article:12916058pubmed:year2003lld:pubmed
pubmed-article:12916058pubmed:articleTitleSynthesis of novel MKC-442 analogues with potent activities against HIV-1.lld:pubmed
pubmed-article:12916058pubmed:affiliationNucleic Acid Center, Department of Chemistry, University of Southern Denmark, Campusvej 55, DK-5230 Odense M, Denmark. EBP@Chen.sdu.dklld:pubmed
pubmed-article:12916058pubmed:publicationTypeJournal Articlelld:pubmed